BiomX Inc. Files Definitive Additional Materials
Ticker: PHGE · Form: DEFA14A · Filed: Apr 1, 2025 · CIK: 1739174
| Field | Detail |
|---|---|
| Company | Biomx Inc. (PHGE) |
| Form Type | DEFA14A |
| Filed Date | Apr 1, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, regulatory-filing, corporate-governance
TL;DR
BiomX filed proxy docs, nothing major, just keeping the SEC updated.
AI Summary
BiomX Inc. filed definitive additional materials on April 1, 2025, related to its proxy statement. The company, formerly known as Chardan Healthcare Acquisition Corp. until April 30, 2018, is involved in the biological products sector. This filing is a routine update and does not appear to contain new financial proposals or significant corporate actions.
Why It Matters
This filing indicates ongoing regulatory compliance and communication with shareholders regarding corporate matters, ensuring transparency in the company's operations.
Risk Assessment
Risk Level: low — The filing is a routine DEFA14A, indicating standard corporate communications rather than a high-stakes event.
Key Players & Entities
- BiomX Inc. (company) — Registrant
- Chardan Healthcare Acquisition Corp. (company) — Former company name
- 20180430 (date) — Date of name change
- 20250401 (date) — Filing date
FAQ
What type of filing is this?
This is a DEFA14A filing, specifically 'Definitive Additional Materials' for a proxy statement.
Who is the registrant?
The registrant is BiomX Inc.
What was BiomX Inc.'s former name?
BiomX Inc.'s former name was Chardan Healthcare Acquisition Corp.
When did the company change its name?
The company changed its name on April 30, 2018.
What is the filing date?
The filing date is April 1, 2025.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on April 1, 2025 regarding BiomX Inc. (PHGE).